New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts, +13

European Journal of Cancer

Surgical OncologyRecist GuidelineMedicineCancer ManagementSolid Tumours +7

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, +8

JNCI Journal of the National Cancer Institute

World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment +15

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, +14

Journal of Clinical Oncology

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, +14

Journal of Clinical Oncology

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Roy S. Herbst, Diane Prager, Róbert Hermann, +10

Journal of Clinical Oncology

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

U. Gatzemeier, Aleksandra Szczęsna, E. Kaukel, +12

Journal of Clinical Oncology

Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth, +6

Journal of Clinical Oncology

Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

Stephen Chan, Kay Friedrichs, D. Noel, +20

Journal of Clinical Oncology

Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor Response

Jeremy J. Erasmus, Gregory W. Gladish, Lyle D. Broemeling, +4

Journal of Clinical Oncology

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Jean-Marc Nabholtz, Carla I. Falkson, J. Szántó, +12

Journal of Clinical Oncology